Rani Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street dips on hot inflation data ahead of Nvidia earnings
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Citi sees an opportunity in Oracle after ’one of the most extreme’ stock drawdowns
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Rani Therapeutics (RANI) IPO Opens Modestly Higher After Weak Pricing
July 30, 2021 12:08 PM EDTToday's IPO for Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) opened for trading at $11.26 after pricing 6,666,667 shares of Class A common stock at a price to the public of $11.00 per share, below the expected $14-$16 range.
BofA Securities, Stifel, Cantor Fitzgerald and Canaccord... More
